Cellosaurus cell line BRCA69D (CVCL_A0QF)

PubMed=22615450; DOI=10.1158/1078-0432.CCR-12-0715
Loo D.T., Alderson R.F., Chen F.Z.-F., Huang L., Zhang W.-J., Gorlatov S., Burke S., Ciccarone V., Li H., Yang Y.-H., Son T., Chen Y., Easton A.N., Li J.C., Rillema J.R., Licea M., Fieger C., Liang T.W., Mather J.P., Koenig S., Stewart S.J., Johnson S., Bonvini E., Moore P.A.
Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity.
Clin. Cancer Res. 18:3834-3845(2012)

Patent=US10683364
Johnson L.S., Moore P.A., Huang L., Loo D.T., Chen F.Z.-F.
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof.
Patent number US10683364, 16-Jun-2020

Patent=US10730945
Johnson L.S., Huang L., Moore P.A., Loo D.T., Chen F.Z.-F.
Antibodies reactive with B7-H3 and uses thereof.
Patent number US10730945, 04-Aug-2020